secwatch.observer — SEC 8-K summary
======================================

Issuer:     Prestige Consumer Healthcare Inc. (PBH)
CIK:        0001295947
Form:       8-K
Filed at:   2023-11-02T23:59:59+00:00
Accession:  0001295947-23-000032
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Prestige Consumer Healthcare Q2 rev $286.3M, EPS $1.07, leverage down to 3.0x
-----------------------------------------------------------------------------

- Q2 FY2024 revenue $286.3M, slightly below prior-year record of $289.3M but ahead of internal outlook.
- Diluted EPS $1.07 vs $1.02 YoY, up 5.4%; net income $53.6M vs $51.0M.
- North American OTC revenue fell 3% to $244.4M; International OTC rose ~12.6% to $41.9M.
- Non-GAAP free cash flow $59.5M, up from $55.2M; covenant leverage ratio improved to 3.0x.
- FY2024 outlook reaffirmed: rev $1,135-1,140M, diluted EPS $4.27-4.32, FCF $240M+.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1295947/000129594723000032/0001295947-23-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1295947/000129594723000032/pbh-20231102.htm
  HTML page:      https://secwatch.observer/filing/0001295947-23-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer